Concepedia

J. A. Johnson

JA

Statistics

Publications

5

Citations

124

H-Index

5

Active since

1987

Affiliations

Eli Lilly (United States)(Current)

J. A. Johnson is an author at Eli Lilly (United States) specializing in neuropharmacology, schizophrenia spectrum disorders, and psychiatry.

Publications per year

1987–2008

5

Publications

5

Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists

Joseph P. Tizzano, Kelly I. Griffey, J. A. Johnson et al. · Neuroscience Letters · 1993 · 51 citations

, , +13

Selective Decreases in MAO-B Activity in Post-Mortem Brains from Schizophrenic Patients with Type II Syndrome

F. Owen, Timothy J. Crow, Chris Frith et al. · The British Journal of Psychiatry · 1987 · 22 citations

, , +14

Middle-ear disease and schizophrenia: case–control study

Peter Mason, Michael Rimmer, Anna Richman et al. · The British Journal of Psychiatry · 2008 · 20 citations · Full text

, , +9

Developmental toxicity of the dopamine agonist pergolide mesylate in CD-1 mice. I: Gestational exposure

J Buelke-Sam, Richard A. Byrd, J. A. Johnson et al. · Neurotoxicology and Teratology · 1991 · 16 citations

, , +17

Muscle mitochondrial ultrastructure in exercise-trained iron-deficient rats

J. A. Johnson, Wayne T. Willis, P. R. Dallman et al. · Journal of Applied Physiology · 1990 · 15 citations

, , +17

1–5 of 5